About 100 reports

The intrathecal pumps market is expected to reach US$ 513.24 million by 2028 from US$ 357.38 million in 2021; it is estimated to grow at a CAGR of 5.3% during 2021-2028. The increasing prevalence of cancer and other chronic conditions, advantages of intrathecal pumps over oral medications, and rise in geriatric population are among...

  • Chronic Pain
  • Infectious Disease
  • Pump
  • World
  • APAC
  • Middle East
  • Pump Sales
  • Chronic Disease Prevalence

Chronic Pain Treatment Market The global chronic pain treatment market valued $80,766.6 million in 2020, from where it is set to reach $162,175.2 million by 2030, at a 7.2% CAGR between 2020 and 2030. This will be majorly because of the geriatric population, which, as per the United Nations (UN), will increase from...

  • Chronic Pain
  • APAC
  • United Kingdom
  • Chronic Disease Prevalence

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Neural Implants Market Report The neural implants market by revenue is expected to grow at a CAGR of ?11% during the period 2020–2025. The global brain implants market is one of the fastest-growing segments in the global neurological...

  • Neurological Disorder
  • Chronic Pain
  • Therapy
  • Psychotic Disorder
  • Ambulatory Care
  • Motor And Generator
  • World
  • Health Expenditure
  • Drug Approval

Fibromyalgia (Fibromyalgia Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Fibromyalgia (Fibromyalgia Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule...

  • Chronic Pain
  • Drug Development
  • World

Chronic Pain Treatment Market Research Report: By Product (Drugs, Devices), Indication (Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia), Application (Musculoskeletal, Neuropathy, Oncology), Distribution Channel (Direct, Indirect), End User (Hospitals, Clinics, Nursing Homes, Research Centers...

  • Chronic Pain
  • World
  • Chronic Disease Prevalence
  • Drug Approval

Intrathecal Pumps Market Size, Share & Trends Analysis Report By Type (Bupivacaine, Morphine), By Application (Spasticity, Pain), By Region (APAC, North America, Europe), And Segment Forecasts, 2021 - 2028 Intrathecal Pumps Market Growth & Trends The global intrathecal pumps market size is...

  • Chronic Pain
  • World
  • APAC
  • North America
  • Drug Approval

Fatigue (Central Nervous System) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Fatigue - Drugs in Development, 2021, provides an overview of the Fatigue (Central Nervous System) pipeline landscape. Fatigue also referred to as tiredness,...

  • Pharmaceutical
  • Chronic Pain
  • World
  • Pharmaceutical Registrations

Gulf Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis,...

  • Chronic Pain
  • Analgesic
  • Oman
  • Saudi Arabia
  • United Arab Emirates
  • Chronic Disease Prevalence
  • Surgical Procedures Performed

U.S. Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis,...

  • Chronic Pain
  • Analgesic
  • United States
  • Chronic Disease Prevalence
  • Surgical Procedures Performed

Germany And Netherlands Medical Marijuana Market Size, Share & Trends Analysis Report By Product (Flower, Oil), By Application (Chronic Pain, Mental Disorder, Cancer), By Country, And Segment Forecasts, 2020 - 2027 Germany And Netherlands Medical Marijuana Market Growth & Trends The Germany...

  • Chronic Disease
  • Marijuana
  • Chronic Pain
  • Flower
  • Netherlands
  • Germany
  • Marijuana Consumption

Report Scope: This report aims to provide a comprehensive study of the global market for neurostimulation technologies/devices. It provides a detailed description of the different types of neurostimulation technologies/devices (invasive and noninvasive) and their current and historical market revenues. Neurostimulation...

  • Chronic Pain
  • Neurological Disorder
  • Psychotic Disorder
  • World

Fatigue - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Fatigue - Pipeline Review, H2 2020, provides an overview of the Fatigue (Central Nervous System) pipeline landscape. Fatigue also referred to as tiredness, exhaustion, lethargy,...

  • Pharmaceutical
  • Chronic Pain
  • World
  • Pharmaceutical Registrations

Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis,...

  • Chronic Pain
  • Analgesic
  • APAC
  • World
  • Europe
  • Chronic Disease Prevalence
  • Surgical Procedures Performed

Global Pain Therapeutics Market - Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players Summary Pain is a multifaceted disorder that can be classified in a multitude of ways. Pain can be classified based on physiology, intensity, temporal...

  • Chronic Pain
  • Therapy
  • Clinical Trial
  • World
  • Drug Approval
  • Number Of Enterprises

LATAM Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute...

  • Chronic Pain
  • Chronic Disease
  • Analgesic
  • Latin America
  • Chronic Disease Prevalence
  • Health Expenditure

Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drug, Antidepressant Drugs, Opioids, and Non-Narcotic Analgesics) and Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, and Fibromyalgia): Global Opportunity Analysis and Industry Forecast,...

  • Analgesic
  • Chronic Pain
  • Opioid
  • World
  • APAC
  • Chronic Disease Prevalence
  • Surgical Procedures Performed

The current practice of medical education and methods of performing surgery and therapy suffer from limitations such as scarcity of subjects to practice on, suboptimal surgical precision, and therapy-related issues including medication misuse and ineffectiveness of the drugs to treat the conditions. Moreover, the outbreak of COVID-19 pandemic...

  • Pathology
  • Medical Education
  • Mental Health
  • Chronic Pain
  • World

INTRODUCTION Over the past few decades, the prevalence of neurological disorders has been increasing at an alarming rate, particularly among the geriatric population across the world. In fact, a Global Burden of Disease study suggested that neurological conditions, which are often associated with serious physical, cognitive...

  • Neurological Disorder
  • Therapy
  • Medical Device
  • Chronic Pain
  • World
  • United States
  • Australia
  • Canada

The Global Pain Management Devices Market size is expected to reach $6.3 billion by 2026, rising at a market growth of 8.5% CAGR during the forecast period. Pain management is a branch of medical science that relieves patients with chronic pain from their suffering. Acute pain has a sudden onset of action, while chronic pain persists for a...

  • Analgesic
  • Chronic Pain
  • World

The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain.Key application areas explored in the research include neuropathic pain, migrane, post-surgical pain, cancer pain, chronic pain and migraine. The research encompasses technological advances across Nav1.7 inhibitors,...

  • Chronic Pain
  • Analgesic
  • Pharmaceutical
  • Biomaterial
  • Cell Therapy

Neurostimulation Devices Market by Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others) Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson’s Disease, Epilepsy, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026 The...

  • Neurological Disorder
  • Psychotic Disorder
  • Chronic Pain
  • World
  • APAC

The neuromodulation market is projected to grow at a CAGR of 8.6% during the forecast period (2020–2025). The global neuromodulation market size is projected to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020, at a CAGR of 8.6%. The growth of this market is driven majorly by factors such as the rising prevalence of neurological...

  • Neurological Disorder
  • Chronic Pain
  • Depression
  • North America
  • APAC
  • Europe
  • Drug Approval
  • Chronic Disease Prevalence

Pain Management Devices Market Size, Share & Trends Analysis Report By Product (Radiofrequency Ablation, Neurostimulation), By Application (Cancer, Neuropathic), By Region, And Segment Forecasts, 2020 - 2027 Pain Management Devices Market Growth & Trends The global pain management devices...

  • Analgesic
  • Chronic Pain
  • Artificial Intelligence
  • World
  • Chronic Disease Prevalence

Hyperalgesia (Central Nervous System) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hyperalgesia - Drugs in Development, 2021, provides an overview of the Hyperalgesia (Central Nervous System) pipeline landscape. Hyperalgesia is an increase...

  • Therapy
  • Monoclonal Antibody
  • Digestive System Disorder
  • Arthritis
  • World

Neurostimulation Devices Market - Scope of the Report This report on the global neurostimulation devices market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the market for the forecast period of 2019 to 2027.The report provides the revenue and volume of the...

  • Chronic Pain
  • Incontinence Product
  • Psychotic Disorder
  • Healthcare
  • Neurological Disorder
  • World

Fibromyalgia - Pipeline Review, H2 2019 Summary Pharmaceutical and Healthcare disease pipeline guide Fibromyalgia - Pipeline Review, H2 2019, provides an overview of the Fibromyalgia (Central Nervous System) pipeline landscape. Fibromyalgia is a disorder characterized by widespread musculoskeletal...

  • Chronic Pain
  • World
  • Drug Approval
  • Health Provider Density

The North America neuromodulation market is projected to reach US$ 6,612.00 millionby2027 from US$3,029.72million in 2019; it is anticipated to grow at a CAGR of 10.6% from 2020 to 2027.Themarket growth is attributed to increasing incidence of neurological disorders and developments in neuromodulation technology across the region. Depression...

  • Neurological Disorder
  • Chronic Pain
  • Personality Disorder
  • Application
  • North America
  • United States
  • Drug Approval
  • Medical Devices Sales

The South & Central America Neuromodulation market was valued at US$ 316.72 million in 2019 and is projected to reach US$ 627.22 million by 2027; it is expected to grow at a CAGR of 9.2% during 2020–2027. The growth of the market is mainly attributed to factors, such as increasing product launches in the market, the rising product innovation...

  • Neurological Disorder
  • Chronic Pain
  • Psychotic Disorder
  • Personality Disorder
  • Application
  • Home Healthcare
  • Central America
  • Drug Approval
  • Medical Devices Sales

Major players in the neurostimulation devices market are Medtronic, Cyberonics, Boston Scientific Corporation, St. Jude Medical, Nevro Corporation, Neuronetics Inc, NeuroPace Inc, NeuroSigma Inc, Cochlear Ltd, and NDI Medical. The global neurostimulation devices market is expected to grow from $5.07 billion in 2021 to $5.74 billion...

  • Medical Device
  • Neurological Disorder
  • Chronic Pain
  • Psychotic Disorder
  • Cardiac Management
  • World
  • APAC
  • United States

The global cryotherapy market reached a value of US$ 292 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 421.9 Million by 2027 exhibiting a CAGR of 6.25% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as...

  • Industrial Gases
  • Arthritis
  • Research And Development
  • Dermatological Condition
  • World